PR Newswire BiotechOriginal article
CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development
PartnershipPositive
AI Analysis
Summary
CellCarta and Imagene AI expanded their collaboration to validate and deploy AI-powered biomarker and companion diagnostic programs. The partnership combines Imagene's AI assay development capabilities with CellCarta's CDx infrastructure and laboratory operations to support active programs with leading pharma partners.
Importance:5/10
Sentiment:
0.60
collaboration expansionAI biomarkerscompanion diagnosticsassay developmentdrug development
Read the original article
Published by PR Newswire Biotech on October 1, 2026 1:15 PM
